At Amicus we are dedicated to making a profound impact on the lives of patients affected by #RareDisease. We are proud to share the recent contributions of our Chief Risk Officer, Patrik Florencio, and Chief Patient Advocate, Jayne Gershkowitz, in Healthcare Business Today, that underscores the vital role of Patient Advocacy Organizations (PAOs) and patient advocates in the rare disease community. PAOs and #PatientAdvocates are uniquely positioned to share their expertise, drawn from both professional and lived experiences, to improve #PatientCare. The article shines a light on the importance of collaboration between the industry and these critical stakeholders. We remain deeply committed to making meaningful impact on the lives of rare disease patients, ensuring that patient voices remain at the heart of everything we do. Read the full article here to learn more: https://bit.ly/3LYljPS #RareDisease #PatientAdvocacy #Leadership #Compliance #Collaboration
Amicus Therapeutics
バイオテクノロジー研究
Princeton 、NJ43,147人のフォロワー
Our passion for making a difference unites us.
概要
We are a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Amicus is the Latin word for friend. This name signifies our collaborative approach to developing medicines by incorporating the patient perspective every step of the way. Our company was founded by an entrepreneur who embarked on a life-long journey to transform the lives of those living with devastating conditions when two of his children were diagnosed with a rare disease. That spirit of empathy, compassion, and tenacity permeates our culture and influences all aspects of our approach to advancing cutting-edge technologies. Building on our core beliefs, our mission-focused behaviors help us define and shape our culture; drive performance and innovation; inform development and growth; and attract, energize, and retain the right talent. By championing mission-dedication, innovation, performance, and integrity, we are united by our passion for making a difference and committed to pushing ideas as far and as fast as possible. Our global footprint spans over 20 countries, including our global headquarters in Princeton, NJ and international headquarters in Marlow, UK. Additional international office locations include Australia, Canada, France, Japan, Germany, Italy, The Netherlands, and Spain. More information about Amicus and our career opportunities can be found at www.amicusrx.com.
- ウェブサイト
-
http://www.amicusrx.com
Amicus Therapeuticsの外部リンク
- 業種
- バイオテクノロジー研究
- 会社規模
- 社員 501 - 1,000名
- 本社
- Princeton 、NJ
- 種類
- 上場企業
- 創立
- 2002
場所
Amicus Therapeuticsの社員
アップデート
-
This morning, Amicus announced its second quarter 2024 financial results. Members of the Amicus senior leadership team will host a conference call and webcast at 8:30 a.m. ET. https://lnkd.in/g3Jkmvp5
Amicus Therapeutics Announces Second Quarter 2024 Financial Results and Corporate Updates | Amicus Therapeutics
ir.amicusrx.com
-
Happy 4th of July! We’re taking the time today to reflect on our history and achievements as a nation, and how we can continue to embody the spirit of independence in all we do. #IndependenceDay
-
-
In honor of #Juneteenth, we celebrate the resilience, strength, and contributions of the African American community. This legacy reminds us of the power of hope in uncertain times. Join us and our LIFTED Employee Resource Group as we honor this day by reflecting on our history and continuing the work toward inclusivity for all.
-
-
We are honored to have received the prestigious Prix Galien UK Award for Best Pharmaceutical Product. This recognition is a true testament to the team at Amicus and encourages us to continue to deliver on our mission for people living with rare diseases. For investors and media.
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) Opfolda® (miglustat) as Best Pharmaceutical Product | Amicus Therapeutics
ir.amicusrx.com
-
We recognize Pride month by celebrating with the global LGBTQ community through the work of our PRISM Employee Resource Group. #AmicusCares #Pride #LGBTQ
-
-
Amicus is the Latin word for “friend”. This name signifies our collaborative approach to developing technologies and incorporating the patient perspective in every step of drug development. Learn more at http://amicusrx.com #raredisease #AmicusCares
-
-
At Amicus, our Veterans’ ERG, SERVE, is a pillar of support for our veteran colleagues. On behalf of SERVE and Amicus, we honor and remember the brave men and women who made the ultimate sacrifice for our freedom. #MemorialDay #AmicusCares
-
-
Our compliance culture is driven by integrity and a commitment to never prioritize short-term profit over sustainable long-term success. Learn more in our 2024 ESG report: bit.ly/4cGt09D #ESG #AmicusCares
-